Sign In

Save up to 80% by drug discount in your pharmacy with "Pharmacy Near Me - National Drug Discount Card"

You can scan QR Code(just open camera on your phone/scan by application) from the image on prescription drug discount card to save it to your mobile phone. Or just click on image if you're on mobile phone.

View Generic:
View Brand:

Miralax - Medication Information

Product NDC Code 11523-7234
Drug Name

Miralax

Type Brand
Pharm Class Osmotic Activity [MoA],
Osmotic Laxative [EPC],
Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
Active Ingredients
Polyethylene glycol 3350 17 g/17g
Route ORAL
Dosage Form POWDER, FOR SOLUTION
RxCUI drug identifier 876193,
876195
Application Number NDA022015
Labeler Name Bayer HealthCare LLC.
Packages
Package NDC Code Description
11523-7234-1 17 g in 1 packet (11523-7234-1)
11523-7234-2 119 g in 1 bottle, plastic (11523-7234-2)
11523-7234-3 238 g in 1 bottle, plastic (11523-7234-3)
11523-7234-4 510 g in 1 bottle, plastic (11523-7234-4)
11523-7234-6 17 g in 1 packet (11523-7234-6)
Check if available Online

Active ingredient

A list of the active, medicinal ingredients in the drug product.
Active ingredient (in each dose) (Bottle Only) Polyethylene Glycol 3350, 17 g (cap filled to line) Active ingredient (in each dose) (Packet Only) Polyethylene Glycol 3350, 17 g

Dosage and administration

Information about the drug product’s dosage and administration recommendations, including starting dose, dose range, titration regimens, and any other clinically sigificant information that affects dosing recommendations.
Directions (Bottle Only) do not take more than directed unless advised by your doctor the bottle top is a measuring cap marked to contain 17 grams of powder when filled to the indicated line (white section in cap) adults and children 17 years of age and older: use once a day fill to top of white section in cap which is marked to indicate the correct dose (17 g) stir and dissolve in any 4 to 8 ounces of beverage (cold, hot or room temperature) then drink do not combine with starch-based thickeners used for difficulty swallowing ensure that the powder is fully dissolved before drinking do not drink if there are any clumps do not use no more than 7 days children 16 years of age or under: ask a doctor Directions (Packet Only) do not take more than directed unless advised by your doctor adults and children 17 years of age and older: use once a day stir and dissolve one packet of powder (17 g) in any 4 to 8 ounces of beverage (cold, hot or room temperature) then drink do not combine with starch-based thickeners used for difficulty swallowing ensure that the powder is fully dissolved before drinking do not drink if there are any clumps do not use more than 7 days children 16 years of age or under: ask a doctor

Inactive ingredient

A list of inactive, non-medicinal ingredients in a drug product.
Inactive ingredients none

Indications and usage

A statement of each of the drug products indications for use, such as for the treatment, prevention, mitigation, cure, or diagnosis of a disease or condition, or of a manifestation of a recognized disease or condition, or for the relief of symptoms associated with a recognized disease or condition. This field may also describe any relevant limitations of use.
Use relieves occasional constipation (irregularity) generally produces a bowel movement in 1 to 3 days

Purpose

Information about the drug product’s indications for use.
Purpose Osmotic Laxative Purpose Osmotic Laxative

Spl product data elements

Usually a list of ingredients in a drug product.
MiraLAX Polyethylene Glycol 3350 POLYETHYLENE GLYCOL 3350 POLYETHYLENE GLYCOL 3350 Colorless upon dissolution MiraLAX Polyethylene Glycol 3350 POLYETHYLENE GLYCOL 3350 POLYETHYLENE GLYCOL 3350 Colorless upon dissolution MiraLAX Polyethylene Glycol 3350 POLYETHYLENE GLYCOL 3350 POLYETHYLENE GLYCOL 3350 Colorless upon dissolution MiraLAX Polyethylene Glycol 3350 POLYETHYLENE GLYCOL 3350 POLYETHYLENE GLYCOL 3350 colorless upon dissolution

Package label principal display panel

The content of the principal display panel of the product package, usually including the product’s name, dosage forms, and other key information about the drug product.
PRINCIPAL DISPLAY PANEL - 17 g × 20 Packet Carton 20 Single Doses #1 DOCTOR RECOMMENDED BRAND MiraLAX ® Polyethylene Glycol 3350, Powder for Solution, Osmotic Laxative Mix-In Pax ® Relieves Occasional Constipation/Irregularity Softens Stool 20 ONCE-DAILY DOSES Bayer Unflavored Powder Dissolves in ANY Beverage! UNFLAVORED POWDER GRIT FREE 20 PACKETS NET WT 0.5 OZ (17g) EACH 20ct Carton PRINCIPAL DISPLAY PANEL - 17 g × 10 Packet Carton 10 Single Doses #1 DOCTOR RECOMMENDED BRAND MiraLAX ® Polyethylene Glycol 3350, Powder for Solution, Osmotic Laxative Mix-In Pax ® Relieves Occasional Constipation/Irregularity Softens Stool 10 ONCE-DAILY DOSES Bayer Unflavored Powder Dissolves in ANY Beverage! UNFLAVORED POWDER GRIT FREE 10 PACKETS NET WT 0.5 OZ (17g) EACH 10ct Carton PRINCIPAL DISPLAY PANEL - 30 Dose (510 g) Bottle Label Easy to Pour Bottle #1 DOCTOR RECOMMENDED BRAND MiraLAX ® Polyethylene Glycol 3350, Powder for Solution, Osmotic Laxative UNFLAVORED POWDER GRIT FREE Relieves Occasional Constipation/Irregularity Softens Stool Bayer 30 ONCE-DAILY DOSES NET WT 17.9 OZ (510 g) 30 Front 30 Dose - Back PRINCIPAL DISPLAY PANEL - Twinpack 2x34 Dose (578 g) Bottle Label Twin Pack! 2 x 34 Doses Easy to Pour Bottle MiraLAX ® Polyethylene Glycol 3350, Powder for Solution, Osmotic Laxative #1 DOCTOR RECOMMENDED BRAND Relieves Occasional Constipation/Irregularity Softens Stool UNFLAVORED POWDER GRIT FREE Bayer 34 ONCE-DAILY DOSES NET WT 20.4 OZ (578 g) 34 Dose Front 34 Dose Back

Spl unclassified section

Information not classified as belonging to one of the other fields. Approximately 40% of labeling with effective_time between June 2009 and August 2014 have information in this field.
Drug Facts

Ask doctor

Information about when a doctor should be consulted about existing conditions or sumptoms before using the drug product, including all warnings for persons with certain preexisting conditions (excluding pregnancy) and all warnings for persons experiencing certain symptoms. The warnings under this heading are those intended only for situations in which consumers should not use the product until a doctor is consulted.
Ask a doctor before use if you have nausea, vomiting or abdominal pain a sudden change in bowel habits that lasts over 2 weeks irritable bowel syndrome

Ask doctor or pharmacist

Information about when a doctor or pharmacist should be consulted about drug/drug or drug/food interactions before using a drug product.
Ask a doctor of pharmacist before use if you are taking a prescription drug

Do not use

Information about all contraindications for use. These contraindications are absolute and are intended for situations in which consumers should not use the product unless a prior diagnosis has been established by a doctor or for situations in which certain consumers should not use the product under any circumstances regardless of whether a doctor or health professional is consulted.
Do not use if you have kidney disease, except under the advice and supervision of a doctor

Keep out of reach of children

Information pertaining to whether the product should be kept out of the reach of children, and instructions about what to do in the case of accidental contact or ingestion, if appropriate.
Keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Questions

A telephone number of a source to answer questions about a drug product. Sometimes available days and times are also noted.
Questions or comments? 1-800-MiraLAX (1-800-647-2529)

Stop use

Information about when use of the drug product should be discontinued immediately and a doctor consulted. Includes information about any signs of toxicity or other reactions that would necessitate immediately discontinuing use of the product.
Stop use and ask a doctor if you have rectal bleeding or you nausea, bloating or cramping or abdominal pain gets worse. These may be signs of a serious condition. you get diarrhea you need to use a laxative for longer than 1 week

When using

Information about side effects that people may experience, and the substances (e.g. alcohol) or activities (e.g. operating machinery, driving a car) to avoid while using the drug product.
When using this product you may have loose, watery, more frequent stools

Pregnancy or breast feeding

Pregnancy or Breast feeding
If pregnant or breast-feeding, ask a health professional before use.

Storage and handling

Information about safe storage and handling of the drug product.
Other information store at 20°-25°C (68°-77°F) tamper-evident: do not use if foil seal under cap, printed with "SEALED for YOUR PROTECTION" is missing, open or broken

Warnings

Information about serious adverse reactions and potential safety hazards, including limitations in use imposed by those hazards and steps that should be taken if they occur.
Warnings Allergy alert Do not use if you are allergic to polyethylene glycol Do not use if you have kidney disease, except under the advice and supervision of a doctor Ask a doctor before use if you have nausea, vomiting or abdominal pain a sudden change in bowel habits that lasts over 2 weeks irritable bowel syndrome Ask a doctor of pharmacist before use if you are taking a prescription drug When using this product you may have loose, watery, more frequent stools Stop use and ask a doctor if you have rectal bleeding or you nausea, bloating or cramping or abdominal pain gets worse. These may be signs of a serious condition. you get diarrhea you need to use a laxative for longer than 1 week If pregnant or breast-feeding, ask a health professional before use. Keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Disclaimer: Do not rely on openFDA or Phanrmacy Near Me to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Source: OpenFDA, Healthporta Drugs API